Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.56844346 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.56844346 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.56844346 |
4 | modulation by symbiont of host immune response (GO:0052553) | 7.56844346 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 7.56844346 |
6 | modulation by symbiont of host defense response (GO:0052031) | 7.56844346 |
7 | neutrophil activation involved in immune response (GO:0002283) | 5.92886347 |
8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.86970021 |
9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.60951221 |
10 | macrophage activation involved in immune response (GO:0002281) | 5.26661256 |
11 | response to peptidoglycan (GO:0032494) | 5.16708227 |
12 | detection of other organism (GO:0098543) | 5.04283911 |
13 | response to host immune response (GO:0052572) | 4.99321340 |
14 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.99321340 |
15 | detection of bacterium (GO:0016045) | 4.90128856 |
16 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.79552839 |
17 | positive regulation of interferon-alpha production (GO:0032727) | 4.76720312 |
18 | positive regulation of antigen processing and presentation (GO:0002579) | 4.63583142 |
19 | immunoglobulin mediated immune response (GO:0016064) | 4.59045566 |
20 | regulation of interferon-alpha production (GO:0032647) | 4.58123435 |
21 | response to host (GO:0075136) | 4.48832336 |
22 | response to host defenses (GO:0052200) | 4.48832336 |
23 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.48832336 |
24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.26639615 |
25 | detection of external biotic stimulus (GO:0098581) | 4.21545838 |
26 | microglial cell activation (GO:0001774) | 4.19794857 |
27 | neutrophil mediated immunity (GO:0002446) | 4.17545152 |
28 | respiratory burst (GO:0045730) | 4.17440386 |
29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.12939692 |
30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.11859208 |
31 | natural killer cell mediated immunity (GO:0002228) | 4.11173002 |
32 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.11173002 |
33 | neutrophil activation (GO:0042119) | 4.09150601 |
34 | regulation of gamma-delta T cell activation (GO:0046643) | 4.09072397 |
35 | granulocyte activation (GO:0036230) | 4.06545110 |
36 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.05926849 |
37 | myeloid cell activation involved in immune response (GO:0002275) | 4.05322021 |
38 | response to muramyl dipeptide (GO:0032495) | 3.96021432 |
39 | regulation of antigen processing and presentation (GO:0002577) | 3.87976783 |
40 | response to interleukin-15 (GO:0070672) | 3.87614426 |
41 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.83360607 |
42 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.78054832 |
43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.77822863 |
44 | negative regulation of cell killing (GO:0031342) | 3.77822863 |
45 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.75155308 |
46 | positive regulation of mast cell activation (GO:0033005) | 3.72145050 |
47 | detection of biotic stimulus (GO:0009595) | 3.69792604 |
48 | macrophage activation (GO:0042116) | 3.66855995 |
49 | type I interferon signaling pathway (GO:0060337) | 3.65373805 |
50 | cellular response to type I interferon (GO:0071357) | 3.65373805 |
51 | response to type I interferon (GO:0034340) | 3.62747651 |
52 | pinocytosis (GO:0006907) | 3.61988920 |
53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56315352 |
54 | regulation of cholesterol storage (GO:0010885) | 3.55322627 |
55 | cellular response to interleukin-15 (GO:0071350) | 3.51722171 |
56 | negative regulation of interleukin-17 production (GO:0032700) | 3.48113583 |
57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.47421292 |
58 | regulation of mast cell degranulation (GO:0043304) | 3.47278591 |
59 | regulation of T cell tolerance induction (GO:0002664) | 3.42425135 |
60 | regulation of mast cell activation (GO:0033003) | 3.40498454 |
61 | B cell mediated immunity (GO:0019724) | 3.40095116 |
62 | positive regulation of interferon-beta production (GO:0032728) | 3.39273497 |
63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.37167393 |
64 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.36461115 |
65 | regulation of mononuclear cell migration (GO:0071675) | 3.34984851 |
66 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.33695816 |
67 | B cell receptor signaling pathway (GO:0050853) | 3.30835947 |
68 | cellular extravasation (GO:0045123) | 3.28459426 |
69 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.28296540 |
70 | regulation of tolerance induction (GO:0002643) | 3.28057872 |
71 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.24875519 |
72 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.24875519 |
73 | myeloid leukocyte mediated immunity (GO:0002444) | 3.23589832 |
74 | negative regulation of phagocytosis (GO:0050765) | 3.23365674 |
75 | I-kappaB phosphorylation (GO:0007252) | 3.23104190 |
76 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.20932693 |
77 | negative regulation of mast cell activation (GO:0033004) | 3.19405790 |
78 | leukocyte mediated cytotoxicity (GO:0001909) | 3.19081489 |
79 | positive regulation of B cell differentiation (GO:0045579) | 3.16440761 |
80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.16247302 |
81 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.15758400 |
82 | regulation of B cell differentiation (GO:0045577) | 3.15288953 |
83 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.13322246 |
84 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.12003273 |
85 | negative thymic T cell selection (GO:0045060) | 3.10955851 |
86 | regulation of leukocyte degranulation (GO:0043300) | 3.10663070 |
87 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.10011108 |
88 | low-density lipoprotein particle clearance (GO:0034383) | 3.09358602 |
89 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.08637302 |
90 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.08343518 |
91 | response to protozoan (GO:0001562) | 3.08198613 |
92 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07599823 |
93 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05009884 |
94 | positive thymic T cell selection (GO:0045059) | 3.03878957 |
95 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.03471949 |
96 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.03471949 |
97 | neutrophil chemotaxis (GO:0030593) | 3.03310907 |
98 | monocyte chemotaxis (GO:0002548) | 3.02078608 |
99 | negative regulation of innate immune response (GO:0045824) | 3.01762176 |
100 | tolerance induction (GO:0002507) | 3.01236001 |
101 | T cell migration (GO:0072678) | 3.00992747 |
102 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.00048439 |
103 | lipoprotein transport (GO:0042953) | 2.99350348 |
104 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.98535219 |
105 | negative T cell selection (GO:0043383) | 2.97839261 |
106 | myeloid leukocyte activation (GO:0002274) | 2.97566183 |
107 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.96875635 |
108 | negative regulation of interleukin-6 production (GO:0032715) | 2.96332477 |
109 | neutrophil migration (GO:1990266) | 2.94378961 |
110 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.93412272 |
111 | lymphocyte mediated immunity (GO:0002449) | 2.92886338 |
112 | cell adhesion mediated by integrin (GO:0033627) | 2.91786128 |
113 | regulation of regulated secretory pathway (GO:1903305) | 2.91584812 |
114 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.90888742 |
115 | NIK/NF-kappaB signaling (GO:0038061) | 2.89048905 |
116 | * leukocyte migration involved in inflammatory response (GO:0002523) | 2.88746696 |
117 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.86986193 |
118 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.86425057 |
119 | leukocyte aggregation (GO:0070486) | 2.86120953 |
120 | germinal center formation (GO:0002467) | 2.85926000 |
121 | positive regulation of leukocyte degranulation (GO:0043302) | 2.85314376 |
122 | myeloid dendritic cell differentiation (GO:0043011) | 2.85121216 |
123 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.82966742 |
124 | positive regulation of mast cell degranulation (GO:0043306) | 2.82688028 |
125 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.82688028 |
126 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.82680292 |
127 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82577089 |
128 | phagosome maturation (GO:0090382) | 2.81498211 |
129 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.81092233 |
130 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.80318864 |
131 | myeloid dendritic cell activation (GO:0001773) | 2.80213967 |
132 | dendritic cell differentiation (GO:0097028) | 2.79414382 |
133 | apoptotic cell clearance (GO:0043277) | 2.78959655 |
134 | positive regulation of macrophage cytokine production (GO:0060907) | 2.78770218 |
135 | defense response to protozoan (GO:0042832) | 2.78657622 |
136 | negative regulation of lipid storage (GO:0010888) | 2.78421846 |
137 | detection of molecule of bacterial origin (GO:0032490) | 2.77110083 |
138 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.75906117 |
139 | negative regulation of interleukin-12 production (GO:0032695) | 2.72587183 |
140 | regulation of integrin activation (GO:0033623) | 2.72528762 |
141 | leukocyte mediated immunity (GO:0002443) | 2.71872161 |
142 | leukocyte degranulation (GO:0043299) | 2.71523390 |
143 | positive regulation of interleukin-12 production (GO:0032735) | 2.71113183 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.73506268 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.68766613 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.82243684 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.65065084 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.54607523 |
6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.31569556 |
7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.97222988 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.50020201 |
9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.31116973 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.10965671 |
11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.05084920 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.95314708 |
13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.89141475 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.77405085 |
15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.75152039 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.66564903 |
17 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.59692097 |
18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.52067988 |
19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.50997954 |
20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.47743219 |
21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.31409349 |
22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.26877017 |
23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.14322879 |
24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07695466 |
25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.00196156 |
26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99654043 |
27 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.97204729 |
28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.94712981 |
29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.93176254 |
30 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.85764265 |
31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.81072774 |
32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80030704 |
33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79376038 |
34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73032190 |
35 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.71973922 |
36 | MAF_26560356_Chip-Seq_TH1_Human | 1.64567139 |
37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64287267 |
38 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.61382722 |
39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.61020500 |
40 | * MYB_26560356_Chip-Seq_TH2_Human | 1.60472588 |
41 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60197439 |
42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53271448 |
43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48439335 |
44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47152780 |
45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46613847 |
46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45183724 |
47 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.45069456 |
48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43455964 |
49 | MYB_26560356_Chip-Seq_TH1_Human | 1.40872555 |
50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39478495 |
51 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.37620845 |
52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37329354 |
53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36215002 |
54 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34308195 |
55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34224864 |
56 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33942776 |
57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30973533 |
58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29238795 |
59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28735925 |
60 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26906187 |
61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26538942 |
62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26419421 |
63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22748644 |
64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21415322 |
65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21232337 |
66 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20727103 |
67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18935412 |
68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17611294 |
69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17557273 |
70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16918222 |
71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15660083 |
72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11833410 |
73 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11346294 |
74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10722279 |
75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08782615 |
76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07050714 |
77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05384547 |
78 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.05381216 |
79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05246520 |
80 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.04169518 |
81 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03759233 |
82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03744650 |
83 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03717127 |
84 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03463181 |
85 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03040085 |
86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.02826593 |
87 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01824930 |
88 | MYC_22102868_ChIP-Seq_BL_Human | 1.01126613 |
89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00139145 |
90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98787785 |
91 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97277378 |
92 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95899916 |
93 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94640486 |
94 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.93428166 |
95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92583905 |
96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92583905 |
97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92453781 |
98 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92031822 |
99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91334124 |
100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91088091 |
101 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.90412784 |
102 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88821350 |
103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87691386 |
104 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.86873379 |
105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86340540 |
106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85671274 |
107 | * MAF_26560356_Chip-Seq_TH2_Human | 0.85034228 |
108 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83206636 |
109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82988232 |
110 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82115676 |
111 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82054548 |
112 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81464211 |
113 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.81067720 |
114 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.79996050 |
115 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79315302 |
116 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79155566 |
117 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78825323 |
118 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.78746578 |
119 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78540402 |
120 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.78484463 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 4.44997837 |
2 | MP0001835_abnormal_antigen_presentation | 4.01520596 |
3 | MP0003303_peritoneal_inflammation | 3.95232957 |
4 | MP0000569_abnormal_digit_pigmentation | 3.94199602 |
5 | MP0003172_abnormal_lysosome_physiology | 3.57934845 |
6 | * MP0003436_decreased_susceptibility_to | 3.25611409 |
7 | MP0006082_CNS_inflammation | 3.25183638 |
8 | MP0002419_abnormal_innate_immunity | 3.08337303 |
9 | MP0004510_myositis | 2.70090624 |
10 | MP0009785_altered_susceptibility_to | 2.68170865 |
11 | * MP0005000_abnormal_immune_tolerance | 2.66472037 |
12 | MP0001790_abnormal_immune_system | 2.54842435 |
13 | MP0005387_immune_system_phenotype | 2.54842435 |
14 | MP0000685_abnormal_immune_system | 2.50056529 |
15 | MP0002148_abnormal_hypersensitivity_rea | 2.49078316 |
16 | MP0005025_abnormal_response_to | 2.46220749 |
17 | MP0002452_abnormal_antigen_presenting | 2.43150086 |
18 | MP0001800_abnormal_humoral_immune | 2.26196533 |
19 | MP0002723_abnormal_immune_serum | 2.17302590 |
20 | MP0003300_gastrointestinal_ulcer | 2.16329603 |
21 | MP0009278_abnormal_bone_marrow | 2.06386091 |
22 | MP0005464_abnormal_platelet_physiology | 2.06051745 |
23 | MP0001819_abnormal_immune_cell | 2.02213179 |
24 | MP0002420_abnormal_adaptive_immunity | 1.99961475 |
25 | MP0009840_abnormal_foam_cell | 1.97288889 |
26 | MP0003183_abnormal_peptide_metabolism | 1.97157140 |
27 | MP0000604_amyloidosis | 1.96181161 |
28 | MP0005671_abnormal_response_to | 1.93857856 |
29 | MP0003448_altered_tumor_morphology | 1.88782341 |
30 | MP0005310_abnormal_salivary_gland | 1.86254062 |
31 | MP0002405_respiratory_system_inflammati | 1.84875841 |
32 | MP0002254_reproductive_system_inflammat | 1.81315480 |
33 | MP0010307_abnormal_tumor_latency | 1.78628092 |
34 | MP0004947_skin_inflammation | 1.77602430 |
35 | * MP0001533_abnormal_skeleton_physiology | 1.75425860 |
36 | MP0005257_abnormal_intraocular_pressure | 1.67640386 |
37 | MP0002132_abnormal_respiratory_system | 1.67268997 |
38 | MP0005174_abnormal_tail_pigmentation | 1.66779836 |
39 | MP0003191_abnormal_cellular_cholesterol | 1.64748156 |
40 | MP0001845_abnormal_inflammatory_respons | 1.62644685 |
41 | MP0005451_abnormal_body_composition | 1.62032761 |
42 | MP0002166_altered_tumor_susceptibility | 1.59265950 |
43 | MP0000343_altered_response_to | 1.56930498 |
44 | MP0003566_abnormal_cell_adhesion | 1.56674157 |
45 | MP0003724_increased_susceptibility_to | 1.54873769 |
46 | MP0003690_abnormal_glial_cell | 1.54851941 |
47 | MP0001853_heart_inflammation | 1.46654576 |
48 | MP0000716_abnormal_immune_system | 1.44777686 |
49 | MP0001545_abnormal_hematopoietic_system | 1.44755828 |
50 | MP0005397_hematopoietic_system_phenotyp | 1.44755828 |
51 | MP0003866_abnormal_defecation | 1.43721645 |
52 | MP0008469_abnormal_protein_level | 1.41633836 |
53 | MP0003075_altered_response_to | 1.37001354 |
54 | MP0002398_abnormal_bone_marrow | 1.33794962 |
55 | MP0000689_abnormal_spleen_morphology | 1.33224704 |
56 | MP0002006_tumorigenesis | 1.31980465 |
57 | MP0000858_altered_metastatic_potential | 1.31967192 |
58 | MP0002998_abnormal_bone_remodeling | 1.27709596 |
59 | MP0005076_abnormal_cell_differentiation | 1.26861949 |
60 | MP0001851_eye_inflammation | 1.26243695 |
61 | MP0009764_decreased_sensitivity_to | 1.21653819 |
62 | MP0010155_abnormal_intestine_physiology | 1.21389528 |
63 | MP0004381_abnormal_hair_follicle | 1.20305465 |
64 | MP0000015_abnormal_ear_pigmentation | 1.20014852 |
65 | MP0004883_abnormal_blood_vessel | 1.18943810 |
66 | MP0002429_abnormal_blood_cell | 1.16742802 |
67 | MP0009333_abnormal_splenocyte_physiolog | 1.15106779 |
68 | MP0005166_decreased_susceptibility_to | 1.14881827 |
69 | MP0000465_gastrointestinal_hemorrhage | 1.14812131 |
70 | MP0002722_abnormal_immune_system | 1.14162421 |
71 | MP0001958_emphysema | 1.14045348 |
72 | MP0001873_stomach_inflammation | 1.11474092 |
73 | MP0005167_abnormal_blood-brain_barrier | 1.09170553 |
74 | MP0002277_abnormal_respiratory_mucosa | 1.08431597 |
75 | MP0002933_joint_inflammation | 1.06321416 |
76 | MP0003091_abnormal_cell_migration | 1.03007668 |
77 | MP0003828_pulmonary_edema | 1.02341818 |
78 | MP0003806_abnormal_nucleotide_metabolis | 1.01132899 |
79 | MP0003656_abnormal_erythrocyte_physiolo | 0.97936120 |
80 | MP0008004_abnormal_stomach_pH | 0.95777806 |
81 | MP0000371_diluted_coat_color | 0.92897719 |
82 | MP0009763_increased_sensitivity_to | 0.86762697 |
83 | MP0002138_abnormal_hepatobiliary_system | 0.86162326 |
84 | MP0005083_abnormal_biliary_tract | 0.85665388 |
85 | MP0003705_abnormal_hypodermis_morpholog | 0.82455328 |
86 | MP0004808_abnormal_hematopoietic_stem | 0.80455787 |
87 | MP0008260_abnormal_autophagy | 0.80255533 |
88 | MP0003045_fibrosis | 0.77973497 |
89 | * MP0005390_skeleton_phenotype | 0.77504803 |
90 | MP0003453_abnormal_keratinocyte_physiol | 0.75496782 |
91 | MP0005023_abnormal_wound_healing | 0.73215400 |
92 | MP0005164_abnormal_response_to | 0.72285860 |
93 | MP0009765_abnormal_xenobiotic_induced | 0.71259237 |
94 | MP0008874_decreased_physiological_sensi | 0.70757494 |
95 | MP0000490_abnormal_crypts_of | 0.70142498 |
96 | MP0002396_abnormal_hematopoietic_system | 0.69480856 |
97 | MP0002332_abnormal_exercise_endurance | 0.69204175 |
98 | MP0003795_abnormal_bone_structure | 0.68856091 |
99 | MP0005197_abnormal_uvea_morphology | 0.68617242 |
100 | MP0000249_abnormal_blood_vessel | 0.68146915 |
101 | MP0008438_abnormal_cutaneous_collagen | 0.67405650 |
102 | MP0002090_abnormal_vision | 0.64370840 |
103 | MP0000703_abnormal_thymus_morphology | 0.63611534 |
104 | MP0001663_abnormal_digestive_system | 0.61207639 |
105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60508319 |
106 | MP0000767_abnormal_smooth_muscle | 0.59745696 |
107 | MP0010352_gastrointestinal_tract_polyps | 0.58405795 |
108 | MP0005075_abnormal_melanosome_morpholog | 0.57935690 |
109 | MP0001915_intracranial_hemorrhage | 0.55429023 |
110 | MP0003634_abnormal_glial_cell | 0.55399157 |
111 | MP0000920_abnormal_myelination | 0.55127626 |
112 | MP0002136_abnormal_kidney_physiology | 0.54759659 |
113 | MP0005319_abnormal_enzyme/_coenzyme | 0.53962184 |
114 | MP0003763_abnormal_thymus_physiology | 0.52462087 |
115 | MP0002019_abnormal_tumor_incidence | 0.49552228 |
116 | MP0001986_abnormal_taste_sensitivity | 0.48093807 |
117 | MP0002693_abnormal_pancreas_physiology | 0.47120523 |
118 | MP0000609_abnormal_liver_physiology | 0.46277868 |
119 | MP0005381_digestive/alimentary_phenotyp | 0.46068677 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.91773419 |
2 | Increased cerebral lipofuscin (HP:0011813) | 6.38591326 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.97436146 |
4 | Vacuolated lymphocytes (HP:0001922) | 5.82524767 |
5 | Eczematoid dermatitis (HP:0000976) | 5.68713130 |
6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.37075914 |
7 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.16075793 |
8 | Abnormality of macrophages (HP:0004311) | 5.09430244 |
9 | Dysostosis multiplex (HP:0000943) | 4.51078361 |
10 | Disinhibition (HP:0000734) | 4.30224165 |
11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.29487703 |
12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.29487703 |
13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.29487703 |
14 | Gastrointestinal infarctions (HP:0005244) | 4.11981401 |
15 | Axonal loss (HP:0003447) | 4.08008656 |
16 | Systemic lupus erythematosus (HP:0002725) | 3.90448852 |
17 | Gingivitis (HP:0000230) | 3.86732942 |
18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.83991995 |
19 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.80387764 |
20 | Mucopolysacchariduria (HP:0008155) | 3.80387764 |
21 | Increased IgE level (HP:0003212) | 3.79522865 |
22 | Mediastinal lymphadenopathy (HP:0100721) | 3.75729021 |
23 | Myositis (HP:0100614) | 3.74113486 |
24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.71033298 |
25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.71033298 |
26 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.71033298 |
27 | Prostate neoplasm (HP:0100787) | 3.68764084 |
28 | Recurrent skin infections (HP:0001581) | 3.68479600 |
29 | Keratoconjunctivitis sicca (HP:0001097) | 3.62571014 |
30 | Encephalitis (HP:0002383) | 3.61150405 |
31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.52542730 |
32 | Obstructive lung disease (HP:0006536) | 3.52542730 |
33 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.52416441 |
34 | Loss of speech (HP:0002371) | 3.52216513 |
35 | Autoimmune thrombocytopenia (HP:0001973) | 3.46215886 |
36 | Orchitis (HP:0100796) | 3.42802096 |
37 | Recurrent fungal infections (HP:0002841) | 3.34481583 |
38 | Agnosia (HP:0010524) | 3.18042023 |
39 | Chest pain (HP:0100749) | 3.16352511 |
40 | Prolonged bleeding time (HP:0003010) | 3.15528482 |
41 | Retrobulbar optic neuritis (HP:0100654) | 3.14512956 |
42 | Optic neuritis (HP:0100653) | 3.14512956 |
43 | Myocardial infarction (HP:0001658) | 3.08535028 |
44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.06817932 |
45 | Stomatitis (HP:0010280) | 3.06191098 |
46 | Episodic fever (HP:0001954) | 3.02864727 |
47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.98203951 |
48 | Periodontitis (HP:0000704) | 2.97110804 |
49 | Hypochromic microcytic anemia (HP:0004840) | 2.86467639 |
50 | T lymphocytopenia (HP:0005403) | 2.85359897 |
51 | Hypochromic anemia (HP:0001931) | 2.81095207 |
52 | Upper motor neuron abnormality (HP:0002127) | 2.79910407 |
53 | Amyloidosis (HP:0011034) | 2.78464677 |
54 | Basal ganglia calcification (HP:0002135) | 2.75987556 |
55 | Thick nail (HP:0001805) | 2.75205908 |
56 | Abnormality of T cell number (HP:0011839) | 2.74485855 |
57 | Increased IgM level (HP:0003496) | 2.71921429 |
58 | J-shaped sella turcica (HP:0002680) | 2.67989602 |
59 | Epistaxis (HP:0000421) | 2.65008045 |
60 | Anorexia (HP:0002039) | 2.64796097 |
61 | Pustule (HP:0200039) | 2.64563841 |
62 | Petechiae (HP:0000967) | 2.64538455 |
63 | Urticaria (HP:0001025) | 2.62300307 |
64 | Panhypogammaglobulinemia (HP:0003139) | 2.62243597 |
65 | Vasculitis (HP:0002633) | 2.59112654 |
66 | Pathologic fracture (HP:0002756) | 2.55914400 |
67 | Hepatosplenomegaly (HP:0001433) | 2.55138085 |
68 | Recurrent viral infections (HP:0004429) | 2.53954146 |
69 | Abnormality of T cells (HP:0002843) | 2.51409654 |
70 | Pulmonary embolism (HP:0002204) | 2.50087865 |
71 | Recurrent cutaneous fungal infections (HP:0011370) | 2.48468133 |
72 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.48468133 |
73 | Glomerulonephritis (HP:0000099) | 2.48353876 |
74 | Cellulitis (HP:0100658) | 2.46758777 |
75 | Granulocytopenia (HP:0001913) | 2.45675685 |
76 | Apathy (HP:0000741) | 2.43889055 |
77 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.43585295 |
78 | Diminished motivation (HP:0000745) | 2.41701335 |
79 | Thoracic kyphosis (HP:0002942) | 2.41500015 |
80 | Lymphopenia (HP:0001888) | 2.40974270 |
81 | Peritonitis (HP:0002586) | 2.40438033 |
82 | Sepsis (HP:0100806) | 2.37844760 |
83 | Abnormality of the lumbar spine (HP:0100712) | 2.36535553 |
84 | Hematochezia (HP:0002573) | 2.35393038 |
85 | Increased serum ferritin (HP:0003281) | 2.34771421 |
86 | Osteomyelitis (HP:0002754) | 2.34711269 |
87 | Hypergammaglobulinemia (HP:0010702) | 2.34033181 |
88 | Gangrene (HP:0100758) | 2.32542199 |
89 | Inappropriate behavior (HP:0000719) | 2.30337593 |
90 | Abnormality of the pleura (HP:0002103) | 2.27932110 |
91 | Global brain atrophy (HP:0002283) | 2.27803390 |
92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26959008 |
93 | Leukocytosis (HP:0001974) | 2.26659558 |
94 | Interstitial pulmonary disease (HP:0006530) | 2.23630309 |
95 | Peripheral demyelination (HP:0011096) | 2.22810784 |
96 | Pulmonary infiltrates (HP:0002113) | 2.20760244 |
97 | Purpura (HP:0000979) | 2.20131128 |
98 | Abnormality of T cell physiology (HP:0011840) | 2.19870259 |
99 | Arterial thrombosis (HP:0004420) | 2.19724713 |
100 | Neuronal loss in central nervous system (HP:0002529) | 2.19665044 |
101 | Skin ulcer (HP:0200042) | 2.15106583 |
102 | Bone pain (HP:0002653) | 2.14158528 |
103 | Glomerulopathy (HP:0100820) | 2.13609787 |
104 | Agammaglobulinemia (HP:0004432) | 2.12908147 |
105 | Gastrointestinal stroma tumor (HP:0100723) | 2.11242999 |
106 | Tetraparesis (HP:0002273) | 2.11154195 |
107 | Personality changes (HP:0000751) | 2.10446490 |
108 | Microcytic anemia (HP:0001935) | 2.10242590 |
109 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09447903 |
110 | Osteolytic defects of the hand bones (HP:0009699) | 2.09447903 |
111 | Chronic otitis media (HP:0000389) | 2.09090608 |
112 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.08366800 |
113 | Conjunctival telangiectasia (HP:0000524) | 2.08041648 |
114 | Abnormality of the peritoneum (HP:0002585) | 2.07826289 |
115 | Abnormality of iron homeostasis (HP:0011031) | 2.07476327 |
116 | Premature loss of primary teeth (HP:0006323) | 2.07302357 |
117 | IgM deficiency (HP:0002850) | 2.05762315 |
118 | Meningitis (HP:0001287) | 2.05530008 |
119 | Recurrent pneumonia (HP:0006532) | 2.03227901 |
120 | Abnormality of the endocardium (HP:0004306) | 2.02913866 |
121 | Gingival bleeding (HP:0000225) | 2.01726844 |
122 | Colitis (HP:0002583) | 2.00775041 |
123 | Slow saccadic eye movements (HP:0000514) | 1.99887257 |
124 | Spontaneous hematomas (HP:0007420) | 1.99782885 |
125 | Abnormality of the prostate (HP:0008775) | 1.99716726 |
126 | Abnormality of the thoracic spine (HP:0100711) | 1.97875211 |
127 | Acne (HP:0001061) | 1.97200903 |
128 | Inflammation of the large intestine (HP:0002037) | 1.96650756 |
129 | Keratitis (HP:0000491) | 1.92807107 |
130 | Abnormality of the pericardium (HP:0001697) | 1.92568849 |
131 | Restrictive lung disease (HP:0002091) | 1.92232943 |
132 | Recurrent bronchitis (HP:0002837) | 1.91132952 |
133 | Progressive visual loss (HP:0000529) | 1.90500170 |
134 | Vertigo (HP:0002321) | 1.89251662 |
135 | Autoimmune hemolytic anemia (HP:0001890) | 1.89143037 |
136 | Asymmetric septal hypertrophy (HP:0001670) | 1.87698610 |
137 | Viral hepatitis (HP:0006562) | 1.87628382 |
138 | Frequent falls (HP:0002359) | 1.87248797 |
139 | Supranuclear gaze palsy (HP:0000605) | 1.85553988 |
140 | Increased CSF protein (HP:0002922) | 1.84180969 |
141 | Vertebral compression fractures (HP:0002953) | 1.83906556 |
142 | Keratoconjunctivitis (HP:0001096) | 1.83704532 |
143 | Nephritis (HP:0000123) | 1.82583281 |
144 | Gastrointestinal inflammation (HP:0004386) | 1.81901393 |
145 | Esophageal varix (HP:0002040) | 1.81312323 |
146 | Mutism (HP:0002300) | 1.80337641 |
147 | Hemoptysis (HP:0002105) | 1.80042835 |
148 | Deformed sella turcica (HP:0002681) | 1.79623847 |
149 | Neurodegeneration (HP:0002180) | 1.78907662 |
150 | Eosinophilia (HP:0001880) | 1.78439815 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 3.61439610 |
2 | KIT | 3.57705752 |
3 | RIPK4 | 3.51871339 |
4 | TBK1 | 3.45284066 |
5 | TYK2 | 3.06936230 |
6 | IRAK4 | 3.00311922 |
7 | PRPF4B | 2.71957333 |
8 | BLK | 2.34413496 |
9 | TNK2 | 2.30953155 |
10 | NME2 | 2.21217118 |
11 | ERN1 | 2.17312713 |
12 | MAP3K13 | 2.16030885 |
13 | IRAK3 | 2.11702983 |
14 | IKBKB | 2.09864803 |
15 | MAP4K1 | 2.09556303 |
16 | FES | 2.08056313 |
17 | TTN | 2.06604364 |
18 | IKBKE | 2.04756057 |
19 | TAOK3 | 2.03982710 |
20 | TAOK1 | 1.94693414 |
21 | JAK3 | 1.93487809 |
22 | CSF1R | 1.82472279 |
23 | JAK1 | 1.77321270 |
24 | HCK | 1.73246884 |
25 | EPHB1 | 1.72885208 |
26 | SIK3 | 1.62124476 |
27 | TGFBR2 | 1.60080127 |
28 | FGR | 1.57011180 |
29 | CSK | 1.54564066 |
30 | SYK | 1.52407360 |
31 | CAMK1D | 1.52004140 |
32 | MAP2K3 | 1.47861854 |
33 | TRIB3 | 1.42963455 |
34 | SIK2 | 1.40559249 |
35 | NEK9 | 1.39431318 |
36 | ZAP70 | 1.35745104 |
37 | CHUK | 1.28649375 |
38 | PIM2 | 1.25986109 |
39 | PTK6 | 1.24447201 |
40 | SCYL2 | 1.23286241 |
41 | STK10 | 1.22183502 |
42 | BTK | 1.20263292 |
43 | LCK | 1.20121576 |
44 | MAP3K3 | 1.19849589 |
45 | PKN2 | 1.16933842 |
46 | JAK2 | 1.12493381 |
47 | LYN | 1.09923454 |
48 | PBK | 1.09381992 |
49 | RPS6KA4 | 1.08982512 |
50 | RIPK1 | 1.07340299 |
51 | CAMK1G | 1.06601607 |
52 | PRKD2 | 1.04274549 |
53 | SMG1 | 1.03065108 |
54 | MARK2 | 1.02866205 |
55 | TXK | 1.02643492 |
56 | TRPM7 | 0.99273096 |
57 | ITK | 0.95176716 |
58 | YES1 | 0.93796519 |
59 | MATK | 0.92091769 |
60 | SIK1 | 0.90052458 |
61 | TEC | 0.89284275 |
62 | IRAK2 | 0.89217621 |
63 | EGFR | 0.88760464 |
64 | IRAK1 | 0.87960971 |
65 | CDC42BPA | 0.83488252 |
66 | LRRK2 | 0.83251974 |
67 | PIM1 | 0.82701747 |
68 | MOS | 0.81645383 |
69 | CAMKK2 | 0.79972711 |
70 | MAP3K11 | 0.78111368 |
71 | BMPR2 | 0.76120140 |
72 | CDK6 | 0.74873493 |
73 | ABL1 | 0.74543990 |
74 | BMX | 0.72823478 |
75 | PRKCD | 0.72318510 |
76 | PAK4 | 0.71741971 |
77 | MAP3K7 | 0.68408864 |
78 | GRK6 | 0.68105041 |
79 | HIPK2 | 0.65408948 |
80 | MARK3 | 0.64581057 |
81 | MAP3K6 | 0.63815792 |
82 | CDK19 | 0.63092718 |
83 | FGFR3 | 0.62677260 |
84 | MAPK12 | 0.62521102 |
85 | CDK12 | 0.60747562 |
86 | ABL2 | 0.58822576 |
87 | STK4 | 0.58218799 |
88 | MAP3K5 | 0.57701403 |
89 | MAPK7 | 0.57319980 |
90 | TESK2 | 0.55658149 |
91 | TAOK2 | 0.54728246 |
92 | FYN | 0.53470082 |
93 | CAMKK1 | 0.53238267 |
94 | KSR2 | 0.53000338 |
95 | TESK1 | 0.52187147 |
96 | DYRK1B | 0.52088259 |
97 | MAP3K9 | 0.52023338 |
98 | MAP3K1 | 0.50485267 |
99 | DAPK2 | 0.49728760 |
100 | RPS6KL1 | 0.49003450 |
101 | RPS6KC1 | 0.49003450 |
102 | PTK2B | 0.48855371 |
103 | FGFR4 | 0.48656748 |
104 | ERBB3 | 0.47492274 |
105 | MAP2K6 | 0.47460491 |
106 | MAPKAPK2 | 0.43071353 |
107 | EPHA3 | 0.42483639 |
108 | STK38 | 0.41970373 |
109 | STK11 | 0.40856613 |
110 | MAP3K8 | 0.40054808 |
111 | MAP2K4 | 0.40040734 |
112 | MAP3K2 | 0.38996099 |
113 | SRC | 0.38434892 |
114 | STK3 | 0.38102510 |
115 | CLK1 | 0.38016126 |
116 | SGK3 | 0.37639711 |
117 | PDPK1 | 0.37532748 |
118 | PRKG2 | 0.37420708 |
119 | GRK7 | 0.35821996 |
120 | PDGFRB | 0.34780501 |
121 | PRKCH | 0.34572589 |
122 | RET | 0.34306839 |
123 | PDK1 | 0.33817965 |
124 | RPS6KA6 | 0.33554014 |
125 | RAF1 | 0.32891001 |
126 | DAPK3 | 0.32811929 |
127 | PTK2 | 0.32224457 |
128 | NEK2 | 0.31327197 |
129 | PRKCQ | 0.30491492 |
130 | IGF1R | 0.29532880 |
131 | CDK4 | 0.28872204 |
132 | RPS6KA2 | 0.27505718 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.16415055 |
2 | Lysosome_Homo sapiens_hsa04142 | 3.12809180 |
3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.10253692 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.05117104 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.61696624 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.55132240 |
7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.36763082 |
8 | Tuberculosis_Homo sapiens_hsa05152 | 2.27009455 |
9 | Phagosome_Homo sapiens_hsa04145 | 2.20752702 |
10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.20228470 |
11 | Pertussis_Homo sapiens_hsa05133 | 2.07003786 |
12 | Malaria_Homo sapiens_hsa05144 | 2.02709531 |
13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.99900431 |
14 | Legionellosis_Homo sapiens_hsa05134 | 1.94648656 |
15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87995339 |
16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.81621637 |
17 | Measles_Homo sapiens_hsa05162 | 1.72996888 |
18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66730676 |
19 | Allograft rejection_Homo sapiens_hsa05330 | 1.61969473 |
20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60750409 |
21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.59479044 |
22 | Apoptosis_Homo sapiens_hsa04210 | 1.58212213 |
23 | Shigellosis_Homo sapiens_hsa05131 | 1.57228111 |
24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55816689 |
25 | Salmonella infection_Homo sapiens_hsa05132 | 1.51833110 |
26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50860354 |
27 | Influenza A_Homo sapiens_hsa05164 | 1.47571150 |
28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.47256940 |
29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.45636734 |
30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45321667 |
31 | Asthma_Homo sapiens_hsa05310 | 1.42328446 |
32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41296292 |
33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40519333 |
34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38020993 |
35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30984635 |
36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30908683 |
37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.27392548 |
38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18155257 |
39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14466953 |
40 | Hepatitis B_Homo sapiens_hsa05161 | 1.13757405 |
41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12482969 |
42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12388694 |
43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12045563 |
44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.10507656 |
45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10480288 |
46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09485997 |
47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.07347268 |
48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05403530 |
49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04981070 |
50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03065971 |
51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99606870 |
52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98917577 |
53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96875654 |
54 | Amoebiasis_Homo sapiens_hsa05146 | 0.96700472 |
55 | Hepatitis C_Homo sapiens_hsa05160 | 0.95848868 |
56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86913352 |
57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.86552116 |
58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83348778 |
59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82362425 |
60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77190928 |
61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76812913 |
62 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76368907 |
63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75562986 |
64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.75523540 |
65 | Endocytosis_Homo sapiens_hsa04144 | 0.73608293 |
66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70848118 |
67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70759606 |
68 | Platelet activation_Homo sapiens_hsa04611 | 0.70291886 |
69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65658740 |
70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64710442 |
71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64251477 |
72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63314227 |
73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.61593894 |
74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61475361 |
75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61408974 |
76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60064310 |
77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58083619 |
78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56984591 |
79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55447986 |
80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54457887 |
81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53500078 |
82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52617364 |
83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51346874 |
84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50906727 |
85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50750314 |
86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49750190 |
87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49055527 |
88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48893107 |
89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48014401 |
90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45860297 |
91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45041072 |
92 | Bladder cancer_Homo sapiens_hsa05219 | 0.42298521 |
93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41634020 |
94 | Mineral absorption_Homo sapiens_hsa04978 | 0.41120628 |
95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40922723 |
96 | Glioma_Homo sapiens_hsa05214 | 0.40518649 |
97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39445037 |
98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39134454 |
99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38959050 |
100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38733029 |
101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38645715 |
102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38547333 |
103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38256630 |
104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37473167 |
105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37348916 |
106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36817131 |
107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36267456 |
108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36137701 |
109 | Focal adhesion_Homo sapiens_hsa04510 | 0.34769674 |
110 | Insulin resistance_Homo sapiens_hsa04931 | 0.32639995 |
111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32144903 |
112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31739452 |
113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31497871 |
114 | Prion diseases_Homo sapiens_hsa05020 | 0.30181267 |
115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29644872 |
116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28832024 |
117 | Prostate cancer_Homo sapiens_hsa05215 | 0.28472008 |